Medadvisor Ltd
ASX:MDR
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
This alert will be permanently deleted.
Medadvisor Ltd
MedAdvisor Ltd. engages in the provision of mobile and web software platform for prescription medication use. The company is headquartered in Melbourne, Victoria. The company went IPO on 2011-05-26. The firm is engaged in the development and delivering software for personal medication management. The Company’s products include MedAdvisor App, PlusOne pharmacy platform. MedAdvisor App and its supporting software platform provides individuals and minders to manage all aspects of prescription medication use. Its cloud-based medication records and data connects pharmacies and other HCPs. The firm provides pharmaceutical health program..
MedAdvisor Ltd. engages in the provision of mobile and web software platform for prescription medication use. The company is headquartered in Melbourne, Victoria. The company went IPO on 2011-05-26. The firm is engaged in the development and delivering software for personal medication management. The Company’s products include MedAdvisor App, PlusOne pharmacy platform. MedAdvisor App and its supporting software platform provides individuals and minders to manage all aspects of prescription medication use. Its cloud-based medication records and data connects pharmacies and other HCPs. The firm provides pharmaceutical health program..
Revenue Decline: MedAdvisor's U.S. business saw a significant drop in revenue in Q1 FY '26, driven by regulatory delays, lower vaccine volumes, and overall sector headwinds.
Vaccine Revenue Hit: Vaccine program revenue plunged 90% year-on-year, especially due to weak RSV and COVID demand and regulatory delays.
Gross Margin Pressure: Gross margins softened due to increased platform costs and a shift in product mix.
Cash & Debt: The company has around $13 million cash, all debt discharged, and expects an additional $8 million from a transaction holdback soon.
Specialty Medication Outlook: Specialty medication revenue fell 18%, but management forecasts solid growth in this segment later in FY '26.
Cost Reductions: Operating expenses are targeted to be at least 15% lower in FY '26 versus FY '25.
Strategic Focus Shift: Strategic options review is now closed; management is prioritizing U.S. business transformation and growth.
Pipeline Adjustment: The health program pipeline is now valued at $100 million after cleanup and some conversions.
